Oral solid dosage forms, their characteristics and the role of pregelatinized starch in oral solid dosage forms
International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)
DOI: 10.25258/ijddt.16.60s.142 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von Gentjan Mataj.
Abstract (Originalsprache)
Background
Oral solid dosage forms represent the most widely used and preferred route of drug administration due to their ease of administration, accurate dosing, stability, and cost-effectiveness. This review provides a comprehensive overview of various oral solid dosage forms including tablets, capsules, powders, and granules, discussing their characteristics, advantages, and limitations.
Objective
To examine the role and significance of pregelatinized starch as a multifunctional excipient in the formulation of oral solid dosage forms, highlighting its physicochemical properties and functional applications. Materials and Methods A comprehensive literature review was conducted using databases including PubMed, Scopus, and Google Scholar to gather relevant information on oral solid dosage forms and the application of pregelatinized starch in pharmaceutical formulations.
Results
Pregelatinized starch is a modified starch derivative obtained by physical or chemical processing of native starch. It exhibits excellent binding, disintegrating, and flow-enhancing properties, making it an ideal excipient for tablet and capsule formulations. Its multifunctional nature allows it to serve as a binder, disintegrant, diluent, and glidant, thereby simplifying formulation development and improving manufacturing efficiency.
Conclusion
Pregelatinized starch plays a critical role in the formulation of oral solid dosage forms due to its versatile functional properties. Its use enhances tablet hardness, reduces friability, improves drug release profiles, and facilitates manufacturing processes. Ongoing research continues to explore novel applications and modifications of pregelatinized starch to further optimize pharmaceutical formulations.
Zitieren
APA
Mataj, G. (2026). Oral solid dosage forms, their characteristics and the role of pregelatinized starch in oral solid dosage forms. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.142
Vancouver
Mataj G. Oral solid dosage forms, their characteristics and the role of pregelatinized starch in oral solid dosage forms. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.142
BibTeX
@article{Mataj2026,
author = {Mataj, Gentjan},
title = {Oral solid dosage forms, their characteristics and the role of pregelatinized starch in oral solid dosage forms},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {60s},
doi = {10.25258/ijddt.16.60s.142}
}
EUVIMED